Cipla Q4FY25 Results: 30% Profit Surge and ₹16 Dividend Spark Investor Interest
India’s pharma giant Cipla has posted a stellar performance in its Q4 FY25 results, with a robust 30% year-on-year rise in net profit and a total dividend payout of ₹16 per share. The company not only exceeded its FY25 margin guidance, but also surprised the Street with higher-than-expected revenue and a special dividend to mark...